National Center for Functional Glycomics

The National Center for Functional Glycomics (NCFG) is an organization that is focused on the development of technology development in glycosciences. They are specifically focused on glycan analysis and molecular mechanisms of glycan recognition by [[protein]}s important in human biology and disease. The center was established at Emory University in 2013 with $5.5 million funding by National Institutes of Health under the leadership of Richard D. Cummings. The center moved to Harvard University in September 2015 and is currently located at Beth Israel Deaconess Medical Center in Boston Massachusetts. The center is affiliated with the Consortium for Functional Glycomics.

The National Center for Functional Glycomics is one of four glycomics-related biomedical technology research resource centers in the United States. These centers provide unique technology and methods in the field of glycomics research. The center is responsible for services and training for outside investigators, as well as providing access and disseminating technologies, methods and software.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.